Goldman Sachs analyst issues NEUTRAL recommendation for SWK on February 5, 2026 10:13PM ET. The previous analyst recommendation was Neutral.SWK was trading at $85.57 at issue of the analyst recommendation.The...
Citigroup analyst issues BUY recommendation for WMT on February 5, 2026 11:37AM ET. The previous analyst recommendation was Buy.WMT was trading at $128 at issue of the analyst recommendation.The overall...
KeyBanc analyst issues OVERWEIGHT recommendation for EMR on February 5, 2026 11:56AM ET. The previous analyst recommendation was Overweight.EMR was trading at $157.32 at issue of the analyst recommendation.The overall...
Barclays analyst issues OVERWEIGHT recommendation for SWK on February 5, 2026 10:48AM ET. The previous analyst recommendation was Overweight.SWK was trading at $84.63 at issue of the analyst recommendation.The overall...
Deutsche Bank analyst issues HOLD recommendation for EMR on February 4, 2026 09:57PM ET. The previous analyst recommendation was Positive.EMR was trading at $157.32 at issue of the analyst recommendation.The...
Evercore ISI analyst issues OUTPERFORM recommendation for ABBV on February 4, 2026 07:35PM ET. The previous analyst recommendation was Outperform.ABBV was trading at $218.69 at issue of the analyst recommendation.The...
UBS analyst issues NEUTRAL recommendation for ITW on February 4, 2026 02:25PM ET. The previous analyst recommendation was Neutral.ITW was trading at $288.28 at issue of the analyst recommendation.The overall...
RBC Capital analyst issues SECTOR PERFORM recommendation for PEP on February 4, 2026 01:21PM ET. The previous analyst recommendation was Sector Perform.PEP was trading at $162.85 at issue of the...
Oppenheimer analyst issues OUTPERFORM recommendation for GWW on February 4, 2026 01:31PM ET. The previous analyst recommendation was Outperform.GWW was trading at $1155 at issue of the analyst recommendation.The overall...
RBC Capital analyst issues OUTPERFORM recommendation for EMR on February 4, 2026 01:45PM ET. The previous analyst recommendation was Outperform.EMR was trading at $152.1 at issue of the analyst recommendation.The...
